2023-04-012024-03-312024-03-31false08682065MCFEAT SCIENCE LIMITED2024-06-11iso4217:GBPxbrli:pure086820652023-04-01086820652024-03-31086820652023-04-012024-03-31086820652022-04-01086820652023-03-31086820652022-04-012023-03-3108682065bus:SmallEntities2023-04-012024-03-3108682065bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3108682065bus:FullAccounts2023-04-012024-03-3108682065bus:PrivateLimitedCompanyLtd2023-04-012024-03-3108682065core:WithinOneYear2024-03-3108682065core:AfterOneYear2024-03-3108682065core:WithinOneYear2023-03-3108682065core:AfterOneYear2023-03-3108682065core:ShareCapital2024-03-3108682065core:SharePremium2024-03-3108682065core:RevaluationReserve2024-03-3108682065core:OtherReservesSubtotal2024-03-3108682065core:RetainedEarningsAccumulatedLosses2024-03-3108682065core:ShareCapital2023-03-3108682065core:SharePremium2023-03-3108682065core:RevaluationReserve2023-03-3108682065core:OtherReservesSubtotal2023-03-3108682065core:RetainedEarningsAccumulatedLosses2023-03-3108682065core:LandBuildings2024-03-3108682065core:PlantMachinery2024-03-3108682065core:Vehicles2024-03-3108682065core:FurnitureFittings2024-03-3108682065core:OfficeEquipment2024-03-3108682065core:NetGoodwill2024-03-3108682065core:IntangibleAssetsOtherThanGoodwill2024-03-3108682065core:ListedExchangeTraded2024-03-3108682065core:UnlistedNon-exchangeTraded2024-03-3108682065core:LandBuildings2023-03-3108682065core:PlantMachinery2023-03-3108682065core:Vehicles2023-03-3108682065core:FurnitureFittings2023-03-3108682065core:OfficeEquipment2023-03-3108682065core:NetGoodwill2023-03-3108682065core:IntangibleAssetsOtherThanGoodwill2023-03-3108682065core:ListedExchangeTraded2023-03-3108682065core:UnlistedNon-exchangeTraded2023-03-3108682065core:LandBuildings2023-04-012024-03-3108682065core:PlantMachinery2023-04-012024-03-3108682065core:Vehicles2023-04-012024-03-3108682065core:FurnitureFittings2023-04-012024-03-3108682065core:OfficeEquipment2023-04-012024-03-3108682065core:NetGoodwill2023-04-012024-03-3108682065core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108682065core:ListedExchangeTraded2023-04-012024-03-3108682065core:UnlistedNon-exchangeTraded2023-04-012024-03-3108682065core:MoreThanFiveYears2023-04-012024-03-3108682065core:Non-currentFinancialInstruments2024-03-3108682065core:Non-currentFinancialInstruments2023-03-3108682065dpl:CostSales2023-04-012024-03-3108682065dpl:DistributionCosts2023-04-012024-03-3108682065core:LandBuildings2023-04-012024-03-3108682065core:PlantMachinery2023-04-012024-03-3108682065core:Vehicles2023-04-012024-03-3108682065core:FurnitureFittings2023-04-012024-03-3108682065core:OfficeEquipment2023-04-012024-03-3108682065dpl:AdministrativeExpenses2023-04-012024-03-3108682065core:NetGoodwill2023-04-012024-03-3108682065core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108682065dpl:GroupUndertakings2023-04-012024-03-3108682065dpl:ParticipatingInterests2023-04-012024-03-3108682065dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3108682065core:ListedExchangeTraded2023-04-012024-03-3108682065dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3108682065core:UnlistedNon-exchangeTraded2023-04-012024-03-3108682065dpl:CostSales2022-04-012023-03-3108682065dpl:DistributionCosts2022-04-012023-03-3108682065core:LandBuildings2022-04-012023-03-3108682065core:PlantMachinery2022-04-012023-03-3108682065core:Vehicles2022-04-012023-03-3108682065core:FurnitureFittings2022-04-012023-03-3108682065core:OfficeEquipment2022-04-012023-03-3108682065dpl:AdministrativeExpenses2022-04-012023-03-3108682065core:NetGoodwill2022-04-012023-03-3108682065core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3108682065dpl:GroupUndertakings2022-04-012023-03-3108682065dpl:ParticipatingInterests2022-04-012023-03-3108682065dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3108682065core:ListedExchangeTraded2022-04-012023-03-3108682065dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3108682065core:UnlistedNon-exchangeTraded2022-04-012023-03-3108682065core:NetGoodwill2024-03-3108682065core:IntangibleAssetsOtherThanGoodwill2024-03-3108682065core:LandBuildings2024-03-3108682065core:PlantMachinery2024-03-3108682065core:Vehicles2024-03-3108682065core:FurnitureFittings2024-03-3108682065core:OfficeEquipment2024-03-3108682065core:AfterOneYear2024-03-3108682065core:WithinOneYear2024-03-3108682065core:ListedExchangeTraded2024-03-3108682065core:UnlistedNon-exchangeTraded2024-03-3108682065core:ShareCapital2024-03-3108682065core:SharePremium2024-03-3108682065core:RevaluationReserve2024-03-3108682065core:OtherReservesSubtotal2024-03-3108682065core:RetainedEarningsAccumulatedLosses2024-03-3108682065core:NetGoodwill2023-03-3108682065core:IntangibleAssetsOtherThanGoodwill2023-03-3108682065core:LandBuildings2023-03-3108682065core:PlantMachinery2023-03-3108682065core:Vehicles2023-03-3108682065core:FurnitureFittings2023-03-3108682065core:OfficeEquipment2023-03-3108682065core:AfterOneYear2023-03-3108682065core:WithinOneYear2023-03-3108682065core:ListedExchangeTraded2023-03-3108682065core:UnlistedNon-exchangeTraded2023-03-3108682065core:ShareCapital2023-03-3108682065core:SharePremium2023-03-3108682065core:RevaluationReserve2023-03-3108682065core:OtherReservesSubtotal2023-03-3108682065core:RetainedEarningsAccumulatedLosses2023-03-3108682065core:NetGoodwill2022-04-0108682065core:IntangibleAssetsOtherThanGoodwill2022-04-0108682065core:LandBuildings2022-04-0108682065core:PlantMachinery2022-04-0108682065core:Vehicles2022-04-0108682065core:FurnitureFittings2022-04-0108682065core:OfficeEquipment2022-04-0108682065core:AfterOneYear2022-04-0108682065core:WithinOneYear2022-04-0108682065core:ListedExchangeTraded2022-04-0108682065core:UnlistedNon-exchangeTraded2022-04-0108682065core:ShareCapital2022-04-0108682065core:SharePremium2022-04-0108682065core:RevaluationReserve2022-04-0108682065core:OtherReservesSubtotal2022-04-0108682065core:RetainedEarningsAccumulatedLosses2022-04-0108682065core:AfterOneYear2023-04-012024-03-3108682065core:WithinOneYear2023-04-012024-03-3108682065core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3108682065core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3108682065core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3108682065core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3108682065core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3108682065core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3108682065core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108682065core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108682065core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108682065core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3108682065core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3108682065core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3108682065core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3108682065core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3108682065core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3108682065core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3108682065core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3108682065core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3108682065core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3108682065core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3108682065core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3108682065core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3108682065core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3108682065core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3108682065core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3108682065core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3108682065core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3108682065bus:Director12023-04-012024-03-3108682065bus:Director22023-04-012024-03-31

MCFEAT SCIENCE LIMITED

Registered Number
08682065
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

MCFEAT SCIENCE LIMITED
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

MCFEAT, Gillian Denise, Dr
SMITH, William Delacey Corbett

Registered Address

Chestnut Field House
Chestnut Field
Rugby
CV21 2PD

Registered Number

08682065 (England and Wales)
MCFEAT SCIENCE LIMITED
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets319,211990
19,211990
Current assets
Debtors417,7929,041
Cash at bank and on hand27,08155,141
44,87364,182
Creditors amounts falling due within one year5(19,718)(22,261)
Net current assets (liabilities)25,15541,921
Total assets less current liabilities44,36642,911
Net assets44,36642,911
Capital and reserves
Called up share capital22
Profit and loss account44,36442,909
Shareholders' funds44,36642,911
The financial statements were approved and authorised for issue by the Board of Directors on 11 June 2024, and are signed on its behalf by:
MCFEAT, Gillian Denise, Dr
Director
Registered Company No. 08682065
MCFEAT SCIENCE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Impairment of non-financial assets policy
Assets which are not carried at fair value are reviewed for evidence of impairment at each reporting date. Where the asset is showing indicators of impairment, the recoverable amount of the asset, is estimated and then compared to the carrying value in the financial statements. Where the carrying amount is in excess of recoverable amount, an impairment loss is recognised in profit or loss.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
2.Average number of employees

20242023
Average number of employees during the year22
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 April 23-1,1551,155
Additions18,4281,40119,829
At 31 March 2418,4282,55620,984
Depreciation and impairment
At 01 April 23-165165
Charge for year1,608-1,608
At 31 March 241,6081651,773
Net book value
At 31 March 2416,8202,39119,211
At 31 March 23-990990
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables8,6888,640
Other debtors7,940-
Prepayments and accrued income1,164401
Total17,7929,041
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables434407
Bank borrowings and overdrafts-60
Taxation and social security17,17719,875
Accrued liabilities and deferred income2,1071,919
Total19,71822,261
6.Directors advances, credits and guarantees
Included in creditors at the balance sheet date is an overdrawn amount of £7940 due to the company from the directors. The loan is interest free and repaid within nine months of the balance sheet date.